ProShares Morningstar Alternatives Solution ETF (ALTS) Stock Price

0.94 ▼ -0.14 (-12.96%)
Open: 1.09 Vol: 8.38M Day's range: 0.9353 - 1.11 Apr 10, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALTS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.97▼ 0.96▼ 0.97▼ 1.08▼ 1.20▼
MA10 0.97▼ 0.97▼ 1.01▼ 1.11▼ 1.34▼
MA20 0.97▼ 1.02▼ 1.06▼ 1.23▼ 1.52▼
MA50 0.98▼ 1.08▼ 1.11▼ 1.43▼ 4.10▼
MA100 1.02▼ 1.11▼ 1.19▼ 1.55▼ 7.79▼
MA200 1.08▼ 1.21▼ 1.31▼ 3.23▼ 22.50▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.005▼ -0.013▼ -0.015▼ 0.106▲
RSI 25.500▼ 20.338▼ 20.309▼ 28.872▼ 34.073▼
STOCH 66.395     11.495▼ 5.736▼ 25.358     7.317▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -99.096▼ -99.734▼
CCI -330.209▼ -102.905▼ -106.902▼ -134.750▼ -115.283▼
Latest Filters Detected On ALTS
▼ RSI $ALTS RSI(14) Crossed Below 30 Set Alert
▼ BREAK $ALTS Price Breaks 60 Days Low Set Alert
▼ BREAK $ALTS Price Breaks 30 Days Low Set Alert
▼ BREAK $ALTS Price Breaks 20 Days Low Set Alert
▼ BREAK $ALTS Price Breaks 10 Days Low Set Alert
ProShares Morningstar Alternatives Solution ETF News
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases
Wednesday, March 25, 2026 08:33 AM
Altimmune, Inc. (NASDAQ:ALT) earns a spot on our list of the top 10 stocks under $5 that could triple. On March 16, 2026, H.C. Wainwright noted growing optimism around pipeline expansion and upside ...
Altimmune, Inc. (ALT) gains analyst support as pemvidutide advances
Saturday, March 07, 2026 11:26 AM
Altimmune, Inc. (NASDAQ:ALT) is one of the best high-return penny stocks to buy right now. On February 13, Titan Partners initiated coverage of Altimmune, Inc. (NASDAQ:ALT) with a Buy rating and a $7 ...
Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
Thursday, February 26, 2026 04:31 AM
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today ...
ALTS historical stock data
date open high low close volume
10/04/26 1.09 1.11 0.9353 0.94 8,376,517
09/04/26 1.09 1.13 1.08 1.08 1,374,259
08/04/26 1.20 1.23 1.10 1.10 1,744,069
07/04/26 1.14 1.17 1.10 1.10 1,078,184
06/04/26 1.16 1.23 1.15 1.16 1,243,079
02/04/26 1.08 1.20 1.06 1.14 4,155,584
01/04/26 1.13 1.18 1.10 1.10 1,543,702
31/03/26 1.12 1.15 1.08 1.11 2,281,031
30/03/26 1.228 1.24 1.00 1.12 5,369,965
27/03/26 1.28 1.30 1.23 1.23 1,575,785
Quote Details
52wk Low:0.935
52wk High:10.95
Vol:8.38M
Avg Vol(3m):42M
1Y Chng:-85.38%
1M Chng:-32.37%
Add to Watch List
More Information
Sector N/A
Index US Composite
Market Cap. 0.00